Radiation-killing tumor cells promote releasing and presenting tumor antigens, up-regulating PD-L1 expression on tumor cells, increasing TME infiltration of CD8+ T cells, and enhancing T cell-mediated immune response, contributing to improved antitumor immune response (128–130). The gene discussed is CD8A; the disease is neoplasm.